Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 2/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | TTR | P02766 | 1/20 | 0.41 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.41 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.41 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.41 |
| ▸ | EGFR | P00533 | 1/20 | 0.41 |
| ▸ | RELA | Q04206 | 1/20 | 0.40 |
| ▸ | GLA | P06280 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | MAOB | P27338 | 1/20 | 0.39 |
| ▸ | PAM | P19021 | 1/20 | 0.38 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7127921 | 1.00 | CYP2C19 (0.50) | CYP2C19NPC1L3MBTL1TTRALOX5 | |
| SCHEMBL19130587 | 1.00 | CYP2C19 (0.50) | CYP2C19NPC1L3MBTL1TTRALOX5 | |
| SCHEMBL28149239 | 0.85 | CYP2C19 (0.47) | CYP2C19NPC1L3MBTL1TTRALOX5 | |
| SCHEMBL16552541 | 0.84 | CYP2C19 (0.50) | CYP2C19NPC1L3MBTL1TTRALOX5 | |
| SCHEMBL6281994 | 0.83 | CYP2C19 (0.48) | CYP2C19NPC1L3MBTL1EGFRRELA | |
| SCHEMBL2789093 | 0.83 | CYP2C19 (0.48) | CYP2C19NPC1L3MBTL1EGFRRELA | |
| SCHEMBL2866773 | 0.82 | CYP2C19 (0.49) | CYP2C19NPC1L3MBTL1TTRALOX5 | |
| SCHEMBL7101868 | 0.82 | CYP2C19 (0.45) | CYP2C19NPC1L3MBTL1EGFRGLA | |
| SCHEMBL7101867 | 0.82 | CYP2C19 (0.45) | CYP2C19NPC1L3MBTL1EGFRGLA | |
| SCHEMBL28096624 | 0.80 | EGFR (0.47) | CYP2C19NPC1L3MBTL1EGFRGLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190010293-A1 | SILICONE COMPOUNDS | THE PROCTER & GAMBLE COMPANY | 2019-01-10 | — | — | US | claimed |
| US-20190010427-A1 | SILICONE COMPOUNDS | THE PROCTER & GAMBLE COMPANY | 2019-01-10 | — | — | US | claimed |
| US-10196338-B2 | Chiral diamine compounds for the preparation of chiral alcohols and chiral amines | UNIVERSITY COLLEGE DUBLIN (IE) | 2019-02-05 | — | — | US | disclosed |
| US-20190010427-A1 | SILICONE COMPOUNDS | THE PROCTER & GAMBLE COMPANY | 2019-01-10 | — | — | US | disclosed |
| US-20190010293-A1 | SILICONE COMPOUNDS | THE PROCTER & GAMBLE COMPANY | 2019-01-10 | — | — | US | disclosed |
| US-6660884-B2 | Catalyst promote synthesis of tertiary alcohols with enantioselectivity; Bicyclo(2.2.1)heptane-1-methane sulfonamide-N,N'-(1S,2S)-1,2-cyclohexanediylbis(2-hydroxy-7,7-dimethyl) -(1R,1'R,2S,2'S,4S,4'S) | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | 2003-12-09 | — | — | US | disclosed |
| US-20030191345-A1 | CATALYSTS, METHODS FOR MAKING SAID CATALYSTS, AND METHODS FOR MAKING CHIRAL COMPOUNDS WITH HIGH ENANTIOSELECTIVITY | TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA, THE | 2003-10-09 | — | — | US | disclosed |
| US-4070374-A | Process for the preparation of aryl substituted aldehydes, ketones and alcohols | GIVAUDAN CORPORATION (US) | 1978-01-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10196338-B2 | Chiral diamine compounds for the preparation of chiral alcohols and chiral amines | ADH1C, ADH1A, ADH5 | CYP2C19 1200/4885NPC1 3354/4885L3MBTL1 4456/4885 |
| US-20030191345-A1 | CATALYSTS, METHODS FOR MAKING SAID CATALYSTS, AND METHODS FOR MAKING CHIRAL COMPOUNDS WITH HIGH ENANTIOSELECTIVITY | COASY, HMGCR, ALKBH1 | CYP2C19 183/4885NPC1 843/4885L3MBTL1 3410/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.